Have a personal or library account? Click to login
Molecular Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib – Single Centre Experience Cover

Molecular Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib – Single Centre Experience

PRILOZI
Volume 36 (2015): Issue 2 (December 2015)
By: Marica Pavkovic,  Rosica Angelkovic,  Marija Popova-Simjanovska,  Sonja Genadieva-Stavric,  Lidija Cevreska and  Aleksandar Stojanovic  
Open Access
|Dec 2015

Metrics

DOI: https://doi.org/10.1515/prilozi-2015-0065 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 179 - 186
Published on: Dec 30, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
chronic myeloid leukemia,
tyrosine kinase inhibitors,
molecular response
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2015 Marica Pavkovic, Rosica Angelkovic, Marija Popova-Simjanovska, Sonja Genadieva-Stavric, Lidija Cevreska, Aleksandar Stojanovic, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 36 (2015): Issue 2 (December 2015)Next article